Please use this identifier to cite or link to this item:
http://hdl.handle.net/11375/26530
Title: | Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth |
Authors: | Kamposioras K Mauri D Papadimitriou K Anthoney A Hindi N Petricevic B Dambrosio M Valachis A Kountourakis P Kopecky J Kuhar CG Popovic L Chilingirova NP Zarkavelis G de Mello RA Plavetić ND Christopoulos C Mostert B Goffin JR Tzachanis D Saraireh HH Ma F Pavese I Tolia M |
Keywords: | Covid-19;international;oncology;recommendations;societies |
Publication Date: | 2020 |
Publisher: | Frontiers Media SA |
Abstract: | <jats:sec><jats:title>Introduction</jats:title><jats:p>Pandemic COVID-19 is an unexpected challenge for the oncological community, indicating potential detrimental effects on cancer patients. Our aim was to summarize the converging key points providing a general guidance in order to support decision making, pertaining to the oncologic care in the middle of a global outbreak.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>We did an international online search in twenty five countries that have managed a surge in cancer patient numbers. We collected the recommendations from thirty one medical oncology societies.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>By synthesizing guidelines for a) oncology service delivery adjustments, b) general and specific treatment adaptations, and c) discrepancies from guidelines comparison, we present a clinical synopsis with the forty more crucial statements. A Covid-19 risk stratification base was also created in order to obtain a quick, objective patient assessment and a risk-benefit evaluation on a case-by-case basis.</jats:p></jats:sec><jats:sec><jats:title>Conclusions</jats:title><jats:p>In an attempt to face these complex needs and due to limited understanding of COVID-19, a variability of recommendations based on general epidemiological and infectious disease principles rather than definite cancer-related evidence has evolved. Additionally, the absence of an effective treatment or vaccine requires the development of cancer management guidance, capitalizing on comprehensive COVID-19 oncology experience globally.</jats:p></jats:sec> |
metadata.dc.rights.license: | Attribution - CC BY |
URI: | http://hdl.handle.net/11375/26530 |
metadata.dc.identifier.doi: | https://doi.org/10.3389/fonc.2020.575148 |
ISSN: | 2234-943X 2234-943X |
Appears in Collections: | Faculty Publications (via McMaster Experts) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
Synthesis of Recommendations From 25 Countries and 31 Oncology Societies How to Navigate Through Covid-19 Labyrinth.pdf | Published version | 489.86 kB | Adobe PDF | View/Open |
Items in MacSphere are protected by copyright, with all rights reserved, unless otherwise indicated.